Market Overview

A Preview Of Organovo's Q3 Earnings

Related ONVO
The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering
Organovo Q2 Earnings Preview
APTI, KODK among premarket gainers (Seeking Alpha)

Organovo Holdings (NYSE: ONVO) unveils its next round of earnings Thursday. Get prepared with Benzinga's ultimate preview for Organovo's Q3 earnings.

Earnings and Revenue

Sell-side analysts are expecting Organovo's loss per share to be near 9 cents on sales of $1.25 million.

In the same quarter last year, Organovo reported a loss per share of 9 cents on sales of $1.15 million. If the company were to report inline earnings when it publishes results Thursday, revenue would be up 8.6 percent from the year-ago period. Organovo's reported EPS has stacked up against analyst estimates in the past like this:


Quarter Q2 2018 Q1 2018 Q4 2017 Q3 2017
EPS Estimate -0.1 -0.1 -0.11 -0.1
EPS Actual -0.09 -0.1 -0.1 -0.09


Q3 EPS Estimate: -9 cents per share
Q3 Revenues Estimate: $1 million

Stock Performance

Shares of Organovo were trading around $1.39. Over the last 52-week period, shares of Organovo have declined 63.71 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already wary of 12-month losses prior to the announcement.

Analyst estimates have not been modified for EPS and revenues over the past 90 days. The popular rating by analysts on Organovo stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

Don't be surprised to see the stock move on comments made during its conference call. Organovo's Q3 conference call is scheduled to begin at 5:00 p.m. ET and can be accessed here.

Posted-In: Earnings News Previews Trading Ideas


Related Articles (ONVO)

View Comments and Join the Discussion!

Long-Running Bull Market With 'Compelling' Fundamentals Unlikely To Slip, Says Argus Analyst

Manitowoc Earnings Preview